Xilis, Inc.
4 private offerings reported to the SEC on Form D since 2016, $110.8M sold in all. Biotech, North Carolina.
- Form D offerings: 4
- Reported sold: $110.8M
- Newest: Apr 25, 2025
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Apr 25, 2025 | — | $19.4M | $19.4M | Xilis, Inc.Biotech · North Carolina | Not amended | 0001231919-25-000033 |
| Jul 14, 2022 | — | $16.5M | $16.5M | Xilis, Inc.Biotech · North Carolina | Not amended | 0001796056-22-000001 |
| Jul 9, 2021 | — | $70.0M | $70.0M | Xilis, Inc.Biotech · North Carolina | Not amended | 0001796056-21-000001 |
| Dec 6, 2019 | — | $4.8M | $4.8M | Xilis, Inc.Other health care · North Carolina | May 21, 2020 | 0001796056-19-000001 |
- Business address
- Durham, NC
- Incorporated in
- Delaware
- All SEC filings
- CIK 1796056 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR